FDA

The United States Pharmacopeia (USP) appreciates the opportunity to provide comments on a potential FDA novel excipient review program. USP...

  Innovation drives progress in the development of new drugs and therapeutic biological products. 48 new drugs and biological products...

From innovative leaps in cancer diagnosis and treatment to the growing force of artificial intelligence in aiding medical discovery, the...

Innovation drives progress. When it comes to innovation in the development of new drugs and therapeutic biological products, FDA’s Center...

The FDA maintains a list of approved new drug application (NDA) drug products that are no longer protected by patents...

In its continuous endeavor to bolster the competitiveness of the generics market, the US Food and Drug Administration (FDA) updated...

The US Food and Drug Administration (FDA) has released draft guidance for public consultation on the use of the Inactive Ingredient Database (IID). The...

A BioPharma Dive article The Food and Drug Administration's top drug regulator sharply criticized the current clinical trial regime, calling...

  12. August 2018 The FDA recently revamped the methods it uses to determine which foreign and domestic drug manufacturing...